Myriad Genetics (MYGN) Return on Capital Employed Growth (1y) (2012 - 2026)
Myriad Genetics (MYGN) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -1,856.00 |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -57.00 |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -47.00 |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 1,386.00 |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 1,344.00 |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 44.00 |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -76.00 |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 2,850.00 |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -961.00 |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | -5,507.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,507.00 |
| Dec 31, 2025 | -5,249.00 |
| Sep 30, 2025 | -6,334.00 |
| Jun 30, 2025 | -4,858.00 |
| Mar 31, 2025 | 935.00 |
| Dec 31, 2024 | 1,209.00 |
| Sep 30, 2024 | 1,655.00 |
| Jun 30, 2024 | 1,106.00 |
| Mar 31, 2024 | -766.00 |
| Dec 31, 2023 | -1,279.00 |
| Sep 30, 2023 | -1,686.00 |
| Jun 30, 2023 | -1,254.00 |
| Mar 31, 2023 | -97.00 |
| Dec 31, 2022 | 379.00 |
| Sep 30, 2022 | 839.00 |
| Jun 30, 2022 | 314.00 |
| Mar 31, 2022 | 463.00 |
| Dec 31, 2021 | 867.00 |
| Sep 30, 2021 | -115.00 |
| Jun 30, 2021 | 3.00 |